Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant pleural mesothelioma.

L Ho1, D J Sugarbaker, A T Skarin

  • 1M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Cancer Treatment and Research
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data driven identification and classification of Chinese medicine syndrome types among functional dyspepsia patients: latent tree analysis (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Genetic polymorphism in <i>Methylenetetrahydrofolate Reductase chloride transport protein 6</i> (<i>MTHFR CLCN6</i>) gene is associated with keratinocyte skin cancer in a cohort of renal transplant recipients.

Skin health and disease·2022
Same author

MATTHEW-WOOD SYNDROME: A CASE WITH DEXTROCARDIA AND STREAK GONADS.

Genetic counseling (Geneva, Switzerland)·2018
Same author

Pacemaker-induced R-on-T phenomenon leading to ventricular fibrillation post cardiac surgery.

Anaesthesia and intensive care·2015
Same author

A comprehensive study of current haemophilia care and outcomes in Singapore.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Missed carotid artery cannulation: a line crossed and lessons learnt.

Anaesthesia and intensive care·2014
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Malignant pleural mesothelioma (MPM) requires early diagnosis and aggressive multimodality treatment for better survival. Referral to specialized centers improves outcomes through advanced diagnostics, surgery, and novel adjuvant therapies.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Oncology

Background:

  • Malignant pleural mesothelioma (MPM) is a challenging cancer with limited curative options.
  • Delayed diagnosis often hinders effective treatment, emphasizing the need for high clinical suspicion.

Purpose of the Study:

  • To highlight the critical role of early diagnosis and specialized care in improving outcomes for malignant pleural mesothelioma.
  • To underscore the necessity of a multidisciplinary approach involving surgery, radiation, chemotherapy, and novel therapies.

Main Methods:

  • Review of current diagnostic and staging modalities for MPM.
  • Analysis of surgical techniques including pleurectomy/decortication and extrapleural pneumonectomy.
  • Evaluation of adjuvant therapies such as radiation, chemotherapy, hyperthermia, and gene therapy.

Related Experiment Videos

Main Results:

  • Early diagnosis and referral to experienced centers reduce tumor spread and improve surgical outcomes.
  • Aggressive surgical debulking, particularly extrapleural pneumonectomy, offers better local control.
  • Multimodality therapy, combining surgery with adjuvant treatments, is essential for long-term survival.

Conclusions:

  • Multimodality therapy is crucial for managing malignant pleural mesothelioma.
  • Specialized centers provide essential resources for diagnosis, staging, and advanced treatment protocols.
  • Ongoing research into novel adjuvant and investigational therapies holds promise for future treatment advancements.